Target intelligence / Profile preview

TBC1 domain family member 20 (TBC1D20)

Target
TBC1D20
Molecular classification
Enzyme, GTPase-activating protein, Rab GTPase regulator[1][4][6][7]
01

Overview

TBC1 domain family member 20 is a protein encoded by the TBC1D20 gene and functions as a GTPase-activating protein (GAP) that regulates Rab GTPases, notably Rab1, Rab2, and Rab18[1][3][6][7]. By stimulating GTP hydrolysis, it inactivates these Rab proteins, which are crucial for vesicle trafficking, endoplasmic reticulum morphology, autophagy, and intracellular protein/lipid handling[1][3][5][7]. Mutations in the TBC1D20 gene disrupt normal cell trafficking and are associated with disorders such as Warburg micro syndrome, characterized by neurological and ocular defects[1][4][5]. There are currently no known therapeutic drugs directly targeting TBC1D20, but its role in intracellular transport processes and disease may make it of future pharmacological interest[1][3][4][5].

Other names
C20orf140WARBM4dJ852M4.2[1][4]
02

Mechanism of action

GTPase-activating protein activity (inactivation of Rab1 and Rab2 GTPases, inactivation of Rab18 for vesicle trafficking and ER function)[1][3][4][6][7]

03

Biological functions

Regulation of vesicle traffickingAutophagyOrganization of the endoplasmic reticulumIntracellular transportRegulation of lipid droplet storage and releaseProtein processing and modification[1][3][4][5][7]
04

Disease associations

Warburg micro syndromeNeurodevelopmental disorders (such as intellectual disability)Eye abnormalities (coloboma, cataracts)Male infertility[1][4][5]
05

Safety considerations

Loss of function mutations can result in severe syndromic presentations (Warburg micro syndrome, intellectual disabilities, eye and reproductive system abnormalities)[1][4][5]
06

Biomarkers

Genetic variants/mutations for Warburg micro syndrome diagnosis[1][4][5]

Beyond the preview

Go deeper on TBC1 domain family member 20 (TBC1D20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBC1 domain family member 20 (TBC1D20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call